Literature DB >> 11755318

Intracellular flavonoids as electron donors for extracellular ferricyanide reduction in human erythrocytes.

Mara Fiorani1, Roberta De Sanctis, Roberta De Bellis, Marina Dachà.   

Abstract

Reduction of extracellular ferricyanide [Fe(CN)(6)](-3) to ferrocyanide by intact cells reflects the activity of a trans-plasma membrane oxidoreductase that, in human red blood cells, utilizes ascorbic acid as an electron donor. We herein report that the flavonoids quercetin and myricetin, while inhibiting dehydroascorbic acid uptake-and thus the erythrocyte ascorbic acid content-effectively stimulate the extracellular reduction of ferricyanide. Other flavonoids such as rutin, acacetin, apigenin, and genistein do not show the same effect. The notion that quercetin or myricetin may serve as an intracellular donor for a trans-plasma membrane oxidoreductase is supported by the following lines of evidence: (i) they afford direct reduction of ferricyanide; (ii) extracellular reduction of ferricyanide was not mediated by direct effects of the flavonoids released by the cells and was abolished by the sulphydryl reagent parachloromercuribenzenesulfonic acid (pCMBS); (iii) the intracellular concentrations of quercetin or myricetin well correlate with increases in ferricyanide reduction; (iv) the intracellular concentration of the flavonoids dramatically declines after ferricyanide exposure. Taken together, the results presented in this study demonstrate that myricetin and quercetin, which accumulate in large amounts in red blood cells, act as intracellular substrates of a pCMBS-sensitive trans-plasma membrane oxidoreductase. This may represent a novel mechanism whereby these flavonoids exert beneficial effects under oxidative stress conditions.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755318     DOI: 10.1016/s0891-5849(01)00762-6

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

Review 1.  Insights into dietary flavonoids as molecular templates for the design of anti-platelet drugs.

Authors:  Bernice Wright; Jeremy P E Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  Cardiovasc Res       Date:  2012-09-27       Impact factor: 10.787

2.  Platelet-mediated metabolism of the common dietary flavonoid, quercetin.

Authors:  Bernice Wright; Trevor Gibson; Jeremy Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

3.  Chemical structures of 4-oxo-flavonoids in relation to inhibition of oxidized low-density lipoprotein (LDL)-induced vascular endothelial dysfunction.

Authors:  Long Yi; Xin Jin; Chun-Ye Chen; Yu-Jie Fu; Ting Zhang; Hui Chang; Yong Zhou; Jun-Dong Zhu; Qian-Yong Zhang; Man-Tian Mi
Journal:  Int J Mol Sci       Date:  2011-08-26       Impact factor: 5.923

4.  Synthesis of Cr(III)-morin complex: characterization and antioxidant study.

Authors:  Qadeer K Panhwar; Shahabuddin Memon
Journal:  ScientificWorldJournal       Date:  2014-01-29

Review 5.  Isoquercetin as an Anti-Covid-19 Medication: A Potential to Realize.

Authors:  Majambu Mbikay; Michel Chrétien
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

6.  Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C₇₀ and C₈₄O₂ Fullerene Derivatives.

Authors:  Felipe F Sperandio; Sulbha K Sharma; Min Wang; Seaho Jeon; Ying-Ying Huang; Tianhong Dai; Suhasini Nayka; Suzana C O M de Sousa; Long Y Chiang; Michael R Hamblin
Journal:  Nanomedicine       Date:  2012-10-29       Impact factor: 5.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.